Presence of cytokeratins in exhaled breath condensate of mechanical ventilated patients  by Gessner, Christian et al.
ARTICLE IN PRESS
Respiratory Medicine (2008) 102, 299–3060954-6111/$ - see fro
doi:10.1016/j.rmed.
Corresponding au
E-mail address: c
1These authors coPresence of cytokeratins in exhaled breath
condensate of mechanical ventilated patients
Christian Gessnera,,1, Hasan Dihazib,1, Susan Brettschneidera,
Stefan Hammerschmidta, Hartmut Kuhna, Klaus Eschrichc,
Thomas Kellerd, Lothar Engelmanna, Ulrich Sacke, Hubert WirtzaaDepartment of Respiratory Medicine, University of Leipzig, Johannisallee 32, 04103 Leipzig, Germany
bDepartment of Nephrology and Rheumatology, Georg-August-University Goettingen, 37075 Goettingen, Germany
cInstitute of Biochemistry, University of Leipzig, 04103 Leipzig, Germany
dACOMED Statistik, Fockestrasse 57, 04275 Leipzig, Germany
eInstitute of Clinical Immunology and Transfusion Medicine, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany
Received 26 February 2007; accepted 30 August 2007
Available online 8 November 2007KEYWORDS
Proteomics;
ARDS;
Mechanical stretch;
Mechanical
ventilation;
Exhaled breath
condensatent matter & 2007
2007.08.012
thor. Tel.: +49 341
h.gessner@web.d
ntributed equallySummary
Exhaled breath condensate (EBC) contains small amounts of protein leaving the lung
by aerosol droplet generation. Protein patterns in EBC might be useful in monitoring acute
and severe pulmonary disease and in particular monitoring of mechanical stress during
ventilation.
EBC (10ml) was collected from 30 ventilated patients with respiratory failure including 24
patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) and from
10 healthy volunteers. Samples were analyzed using gel electrophoresis. Bands were
characterized by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF).
In the EBC of mechanically ventilated patients 53.3% exhibited three bands (50–70 kDa),
26.7% two bands, 10% one band, and 10% had no bands. While no bands were detected in
volunteers EBC. MALDI-TOF analysis identified these bands as cytokeratins 2, 9 and 10.
Cytokeratins 2 and 10 were confirmed by Western blot. The detection rate of cytokeratins
was correlated to peak inspiratory pressure, positive endexpiratory pressure and ARDS
score, but not with inflammatory markers or smoking status.
Cytokeratins are present in EBC of mechanically ventilated patients. A strong correlation
with parameters of ventilatory stress, such as increased distension, presence of lung injury
and time of ventilation suggests a relation with ventilator-associated damage to the
pulmonary parenchyma.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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to this study.
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C. Gessner et al.300Introduction suggesting that cytokeratins are indicators of lung damage,Exhaled breath condensate (EBC) consists of water vapor
and aerosolized droplets. The aerosolized droplet fraction
contains small amounts of proteins and other components of
the extracellular lining fluid of the lung. The usefulness of
these ingredients for a non-invasive monitoring of pulmon-
ary disease has recently been investigated.1–3 EBC has been
used predominantly to monitor inflammatory lung diseases
such as asthma,4 COPD,5,6 interstitial lung disease7 and the
acute respiratory distress syndrome (ARDS).8,9 Investigations
of EBC most frequently have focused on H2O2, 8-isopros-
tanes, eicosanoids, and cytokines.10
Although the quantification of well-known biochemical
parameters in various lung diseases is of course worthwhile,
the identification of new markers of lung injury is another
challenging task. Methods of proteomics have been used to
characterize various biological fluids such as serum, urine,
bronchoalveolar lavage11 and have also begun to be applied
to EBC.2,12 Protein patterns of EBC for example were
investigated using two-dimensional electrophoresis.12 The
authors of this study demonstrated a corresponding protein
pattern in EBC and in saliva for a majority of the proteins
detected. A contamination of EBC by saliva could be
excluded via analysis of amylase which was present in saliva
samples but not detectable in EBC. EBC analysis of proteins
in another study using tandem electrospray mass spectro-
metry in a pooled sample from 8 healthy non-smokers has
identified cytokeratins 9 and 1.2 These authors have also
reported a significantly increased amount of keratins in
smokers compared to non-smokers using quantitative eva-
luation of spot volume of one-dimensional electrophoresis.
The purpose of the present study was to investigate the
protein pattern in EBC of mechanically ventilated patients in
order to identify possible markers of injury during mechan-
ical ventilation. The identification of markers indicating
tissue damage in response to mechanical during mechanical
ventilation may provide the opportunity to adopt the
ventilation pattern to the lung tissue response in the future.
Significant associations between cytokeratin detection
frequencies and peak inspiratory pressure (PIP), positive
endexpiratory pressure (PEEP) as well as clinical scores of
lung injury and the duration of ventilation were observedTable 1 Ventilatory parameters of all patients classified accor
Criteria Number of
patients
Classification of ALI and ARDS of the American-European consen
No lung injury n ¼ 6
ALI criteria n ¼ 17
ARDS criteria n ¼ 7
Murray’s lung injury score
No lung injury (Score: 0) n ¼ 4
Mild-to-moderate lung injury (Score: 0.1–2.5) n ¼ 17
Severe lung injury (Score: 42.5) n ¼ 9
PEEP: positive end-expiratory airway pressure, PIP: peak inspirato
adapted to body weight.most likely caused by mechanical ventilation.
Material and methods
Patients
A total of 30 patients mechanically ventilated through an
endotracheal tube (16 male, 14 female; age: 54715) and 10
healthy volunteers (5 male, 5 female; age: 48711) were
included in this study. All ventilated patients suffered from
severe pneumonia and acute respiratory failure that
required mechanical ventilation for a minimum of 24 h.
Patients were included into the study when they were stable
with respect to hemodynamics (no change in i.v. catecho-
lamines of more than 25% of baseline) and respiration (no
alteration in ventilator settings). A time frame of up to 24 h
was allowed to reach a stable situation. In the following
time 0–72 h EBC collection was performed when ventilator
settings were unaltered during the 24 h prior to EBC
collection. Thus, all EBC collections were performed in
between 48 and 96 h following the onset of ventilation.
Ventilatory parameters at the time of EBC collection are
listed in Table 1. All patients were ventilated by pressure
control mode.
The extent of acute lung injury (ALI) was estimated at the
time of EBC collection using the criteria of the American-
European Consensus Conference on ARDS (AECC)13 as well as
Murray’s Lung Injury Severity Score (LISS).14 Approval for
this investigation was received from the ethics committee of
the University of Leipzig.
EBC collection
EBC was collected by inserting a special conduit (FILT Lung
and Chest Diagnostics Ltd.; Berlin Germany) for the
EcoScreens breath condensate collecting device (Jaeger-
Toennies; Hoechberg, Germany) into the expiratory limb of
the ventilator tubing. Collecting time for EBC was 30min. All
patients were ventilated with identical humidification
conditions (external humidifiers (Respiflow, Fa. Kendall,
Mansfield, MA, USA) filled with ddH2O at 39 1C).ding to both classifications (AECC and LISS definitions).
PEEP
(mbar)
PIP (mbar) BF (/min) Vt (ml/kgBW)
sus conference
6.573.7 16.076.1 23.272.5 6.371.1
10.673.2 22.474.6 23.873.1 5.871.0
15.675.6 29.177.0 28.377.1 6.071.5
5.070.0 14.071.8 22.572.9 5.971.0
9.672.9 21.675.0 23.973.1 5.971.0
16.174.3 28.676.5 27.276.5 6.071.4
ry airway pressure, BF: breathing frequency, Vt: tidal volume
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healthy volunteers breathing spontaneously through a
standard mouthpiece of the EcoScreens system using a
nose clip for an equivalent collection period of 30min as was
previously described.15
In order to determine cytokeratin background as a source
of contamination by environmental air five condensate
samples were collected from an artificial lung setup
ventilated with identical humidification conditions and
ventilator setups.
Mediators and serum markers
In order to exclude contamination by saliva the EBC samples
were examined for amylase activity (alpha-Amylase ESP1491300
kit; detection limit 0.05mmol/l s ( ¼ 0.003U/ml); Boehringer
Mannheim, Germany).
Five milliliters aliquots of EBC were lyophilized, recon-
stituted in 500 ml and used in IL-6 and IL-8 ELISA assays
(Quantikine HS human IL-6, QuantiGlo human IL-8, R&D
Systems, USA). In addition, IL-6, IL-8 (Immulite, DPC
Biermann, Germany), procalcitonin (LUMItest PCT, BRAHMS
Diagnostica, Germany), and C-reactive protein (Tina-quant
CRP, Roche Diagnostics, Germany) were measured
from serum concomitantly. Protein concentration in EBC
was measured using the Micro-BCA Protein Assay (Pierce,
Rockford, USA).
EBC preparation and gel electrophoresis
For each sample, 10ml of condensate was freeze-dried.
Pellets were reconstituted in 30 ml Tris/HCl buffer pH 7.4.
Protein concentrations were measured using the Bradford
method,16 with bovine serum albumin as a standard. Protein
samples were then diluted in Laemmli buffer (50mM Tris–Cl
pH 6.8; 2% w/v SDS; 0.1% Bromophenolblau; 10% (v/v)
Glycerol, and 5% (v/v) b-mercaptoethanol) and denatured at
95 1C for 10min. SDS–polyacrylamide gel electrophoresis
(PAGE) was performed at room temperature using 12%
acrylamide gels (16 20 0.1).17 Protein bands were
stained with a SilverQuest kit (Invitrogen, Karlsruhe,
Germany).
Preparation of proteins and proteolytic fragments
for matrix-assisted laser desorption/ionization-time
of flight (MALDI-TOF)-MS
The in-gel digestion of the proteins was performed accord-
ing to Dihazi et al.18 Silver-stained proteins were destained
with chemical reducers to remove the silver according to
the protocol provided by the manufacturer (Invitrogen).
When the gel bands become colorless, gel pieces were
washed twice with water, dehydrated in acetonitrile (ACN)
and finally dried in a vacuum centrifuge. Dithiothreitol
(DTT) (10mM) in 100mM NH4HCO3 was added to cover the
gel pieces, and the protein was reduced for 1 h at 56 1C.
After cooling to room temperature, DTT was replaced by
60mM iodoacetamide in 100mM NH4HCO3. Following 45-min
of incubation at room temperature in the dark, gel pieces
were washed with 100mM NH4HCO3 for 10min, dehydrated
by addition of ACN, swollen by rehydration in 100mMNH4HCO3, and shrunk again by addition of the same volume
of ACN. The liquid phase was removed, and the gel pieces
were dried in a vacuum centrifuge. The gel pieces
were swollen in digestion buffer containing 50mM NH4HCO3,
5mM CaCl2, and 10 ng/ml of trypsin (sequencing grade,
Sigma) on ice. After 45min, the supernatant was removed
and replaced by 100 ml of the same buffer without trypsin
to keep the gel pieces hydrated during the enzymatic
cleavage at 37 1C overnight. Peptides were extracted
by adding 5% formic acid in 50% ACN for 20min at room
temperature. After drying down, the resulting peptides
were reconstituted in 0.1% TFA and desalted using a
Ziptip C18 ion exchange column (Millipore, Eschborn,
Germany).
The extracted peptides were then co-crystallized with
matrix (a-cyano-4-hydroxycinnamic acid) on a stainless
steel target using 1 ml matrix and 1 ml sample. A Bruker
Biflex III time-of-flight mass spectrometer (Bruker Daltonik,
Germany), operating in reflector mode with an accelerated
voltage of 20 kV was used to generate peptide mass
maps. Mass spectra were obtained by averaging 50 individual
laser shots. All samples were externally calibrated with a
peptide mix consisting of des-Arg-bradykinin ([M+H]+
904.46), angiotensin I ([M+H]+ 1296.68), Glu1-fibrinopeptide
B ([M+H]+ 1570.67), ACTH (1–17) ([M+H]+ 2093.08),
ACTH (18–39) ([M+H]+ 2465.19) and the resulting mass
spectra were internally calibrated with trypsin autolysis
products (m/z 842.50 and m/z 2211.10). Monoisotopic
peptide masses were assigned and then used in database
searches.
Database search
Protein identification was carried out using MALDI-MS, based
on peptide mass fingerprinting.19 Database searches of
peptide masses were done in the MSDB and NCBInr databases
using the Mascot peptide mass fingerprint software provided
by Matrix Science (Oxford, UK).20 Carboxamidomethylation
and methionine oxidation were considered as variable
modifications. A database search was performed so that
each hit was inspected visually following identification
in order to match as much spectral information as possible.
Criteria for selection were: optimized mass accuracy
(ca. 50 ppm), minimal mass deviation (in the mDa range),
maximized sequence coverage, highest possible probability
score, and maximal number of intense ion signals had to be
assigned to the identified protein.
Western blot analysis
Western blot analyses were performed according to Towbin
et al.21 Fifteen microliter per lane of EBC sample (7.5 mg
protein) were loaded after denaturation with Laemmli
buffer on 10% SDS–gel. After SDS–PAGE, blotting was
performed on nitrocellulose membranes (Amersham
Pharmacia Biotech, Buckinghamshire, UK) at 250mA for
24 h in transfer buffer (25mmol/l Tris–HCl pH 8.4,
192mmol/l glycine, 0.5% SDS, 20% methanol). Membranes
were blocked in 5% non-fat dry milk in PBS-buffer containing
0.1% Tween-20 for 2 h at 37 1C. Primary monoclonal
antibodies against cytokeratin (CK) 2E (Clone Ks2.342.7.1,
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from RDI (Research Diagnostik, Inc.). Proteins were visua-
lized with peroxidase-coupled secondary antibody (Amer-
sham Bioscience), using enhanced chemoluminescence (ECL)
for detection (Amersham Bioscience).
Statistical analysis
Statistical analysis was performed with the SPSS software
package (SPSS 11.0, SPSS Inc.; Chicago, IL, USA) and tests
were chosen according to a professional statisticians advice.
Results are medians and interquartile ranges. The degree of
association between parameters was investigated by Spear-
man’s rank correlation (Spearman rank correlation coeffi-
cient; Rho). Statistical significance was accepted at the 5%
level using a Bonferroni correction in case of multiple
testing (5%/N, N—number of tests). The concordance of
cytokeratin detection by gel electrophoresis and Western
blotting was shown by Cohen’s Kappa.
Results
Identification of keratin isoforms in EBC samples
SDS-electrophoresis of concentrated EBC samples exhibited
bands in the molecular range of 50–65 kDa in 87% (26/30)
mechanically ventilated patients and in none of 10 controls
(sample in Figure 1). Three bands (all cytokeratins) were
observed in 14 out of 26 patients (47%), two bands (two
cytokeratins: 8CK-10, 1CK-2, 7CK-9) were seen in 8
patients (27%)and only one band (one cytokeratin: 1
CK-10, 1CK-2, 2CK-9) was seen in 4 patients (13%). NoFigure 1 Sample of SDS–gel electrophoresis in mechanically ven
(S: standard; P: patient).
Table 2 Summary of the identification results obtained after in
MS analysis and data base search.
Protein Molecular weight (kDa)
Cytokeratin 2 65.8
Cytokeratin 9 62.1
Cytokeratin 10 56.5protein band was observed in the five samples taken from
the artificial lung.
Protein band analysis by MALDI-TOF-MS including data
base searches resulted in the identification of cytokeratins 2
(CK-2), 9 (CK-9) and 10 (CK-10) (Table 2) equivalent to the
three protein bands. In mechanically ventilated patients
cytokeratin CK-2 was found in 16 of 30 (53%) cases,
cytokeratin CK-9 in 24 of 30 (80%) cases, and cytokeratin
CK-10 in 23 of 30 (76.7%) cases.Detection of EBC cytokeratins and clinical
parameters
The frequency of bands detected by gel electrophoresis was
compared with individual clinical data. For this purpose
patients were grouped into three groups depending on the
number of bands detected: no or 1 band, 2 bands, and 3
bands. There was no correlation between the number of
bands and gender, age, weight, height, and smoking status
(Spearman’s rank correlation). Ventilated patients divided
into groups according to the number of protein bands
detected (no cytokeratin, CK-1, CK-2, and CK-3 cytokeratin
bands detected) were also correlated with (a) ventilatory
parameters: PEEP, PIP, tidal volume adjusted to ideal body
weight (Vt), breathing frequency (BF); time of ventilation up
to EBC collection, (b) with clinical scores describing the
extent of ALI: AECC score13 and Murray’s LISS,14 outcome,
and finally (c) indicators of inflammation such as IL-6 and IL-
8 in EBC and C-reactive protein (CRP), procalcitonin (PCT),
IL-6 and IL-8 in serum (Table 3).
With increasing PEEP and PIP more cytokeratin bands
were detected (Figure 2). In respect to indicators of severitytilated patients (A) with characterization of cytokeratins (B)
-gel-digestion of the 3 protein bands with trypsin, MALDI-TOF
Isoelectric point Score fingerprint (Mascot)
7.60 125
5.14 156
5.05 170
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Parameter Detection frequency of cytokeratins
Spearman-Rho p-Value
(A) Spearman’s rang correlation (Spearman-Rho) of ventilatory parameters and clinical scores with detection frequency of
cytokeratins as well as with every individual cytokeratin in the group of mechanically ventilated patients (patients: n ¼ 30;
significance level with Bonferroni correction: o0.0005)
PEEP (mbar) 0.60 0.00049
PIP (mbar) 0.78 0.00001
Vt (ml/kg BW) 0.19 0.32
BF (/min) 0.26 0.16
PaO2/FiO2 0.59 0.00067
Murray’s LISS 0.61 0.00034
Time of ventilation (hours) 0.57 0.00098
Outcome 0.33 0.07
Parameter Median Detection frequency of cytokeratins
Spearman-Rho p-Value
(B) Spearman’s rang correlation (Spearman-Rho) of inflammatory parameters with detection frequency of cytokeratins as well
as with every individual cytokeratin in the group of mechanically ventilated patients (patients: n ¼ 30; significance level with
Bonferroni correction: o0.0005)
CRP (serum) (mg/l) 96.8 0.02 0.90
PCT (serum) (mg/l) 1.0 0.28 0.12
IL-6 (serum) (pg/ml) 48.2 0.12 0.51
IL-8 (serum) (pg/ml) 26.2 0.05 0.79
IL-6 (EBC) (pg/ml) 9.3 0.01 0.95
IL-8 (EBC) (pg/ml) 11.3 0.06 0.77
Cytokeratins in EBC in acute lung injury 303of lung injury an increase in the number of EBC cytokeratins
was detected with increasing lung injury scores (LISS) and
less so for the AECC score (Figure 3). No correlation was
found between outcome and detection rate of cytokeratins
(Table 3).
None of the indicators of inflammation in EBC or in serum
showed any correlation with the number of cytokeratins
detected or with the frequency of detection of the
cytokeratins in EBC.
Protein concentrations between mechanically ventilated
patients (median: 9.3 mg/ml) and healthy volunteers
(median: 8.3 mg/ml) did not significantly differ (Mann–
Whitney test: p ¼ 0.55). In addition, there was no correla-
tion between detection rate of cytokeratins in EBC and
protein concentration in EBC.
Smoking status (ventilated patients: non-smoker: 17, smoker:
13; healthy volunteers: non-smoker: 5, smoker: 5) did not
correlate with cytokeratin detection rate whether in all
subjects nor in subgroup of mechanically ventilated patients.Cytokeratin detection by gel electrophoresis and
Western blotting
The results of gel electrophoresis were crosschecked by
Western blot analysis for CK-2 (example in Figure 4A) and
CK-10 (example in Figure 4B) in a subgroup of 21 patients.
For CK-2 we observed concordant results with both methods
(po0.0001; Kappa: 1.0). The same was true for cytokeratinCK-10 with the exception of a single case (po0.0001;
Kappa: 0.8), in which CK-10 was not detected in the
Western blot.Discussion
We here describe the identification of cytokeratins CK-2,
CK-9, and CK-10 in EBC of mechanically ventilated patients.
Cytokeratins are intermediate-sized filaments in human
tissues composed of at least 19 polypeptides, which are
expressed in cell-type specific combinations related to the
state and the differentiation of the specific epithelial cell.
Bronchial and alveolar epithelial cells but not alveolar
septa, capillaries and other non-epithelial elements were
positively stained with fluorescent-labeled anti-cytokeratin
antibodies.22 Several studies have been performed to
identify cytokeratin specific for lung cancer.23 In contrast,
there are no reports on the effects of mechanical stress on
the pattern of cytokeratin expression in lung parenchyma.
Cytokeratins identified in this study have also been
described in squamous epithelium or epidermis. In human
skin tissue cytokeratin expression changes with elevated
levels of physical stress.24,25 The data presented in this
study do not allow identifying the cells of origin for
cytokeratins or the reason for their increased presence in
EBC. However, the association of mechanical stress during
ventilation and a change in cytokeratin expression in the
lung may constitute a similar response to that in skin. An
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Figure 2 Increasing PEEP and/or PIP (given in cm H2O) was
associated with a higher detection rate of cytokeratins
(classified as no or 1 band, 2 bands, and 3 bands) in SDS–gel
electrophoresis.
Figure 3 Increasing disease severity characterized by PaO2/FiO2
(according to criteria of the American-European Consensus
Conference on ARDS (AECC) and of Murray’s Lung Injury Severity
Score (LISS) associated with higher detection frequency of
cytokeratins (no or 1 band, 2 bands, and 3 bands) in SDS–gel
electrophoresis.
Figure 4 Examples of cytokeratins CK-2 (A) and CK-10 Western
blotting (B) in mechanically ventilated patients (S: standard;
P: patient; NK: negative control; PK: positive control).
C. Gessner et al.304alternative explanation for the presence of cytokeratins in
EBC, i.e. a contamination of EBC with cytokeratins during
collection and preparation does not seem very likely since
detection of cytokeratins in this case would also be
expected in samples from the spontaneously breathing
individuals, or from the artificial lung and in addition would
not be expected to correlate with ventilatory parameters.
In order to exclude contamination of EBC we used
disposable parts and washed those that were not disposable,
such as the conduit for the expiratory limb of the ventilatory
tubing thoroughly and repeatedly between sample collec-
tions. In addition, the cytokeratins detected in EBC from
ventilated patients do not represent a typical mixture from
skin or hair isoforms as would be expected in case of
external contamination.26 Still, the absence of cytokeratin
bands in EBC of spontaneuos breathing patients and in
samples from the artificial lung setup remains in contrast to
the report of Hoffmann et al.27 who described cytokeratins
in spontaneously breathing patients. Significant oropharyn-geal contamination is unlikely in our investigation, since no
amylase activity could be detected in EBC and no amylase
bands were detected on the gels.
Marked differences in total protein concentrations might
account for differences in the number of cytokeratins
detected in EBC. We therefore measured total protein
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observe significant differences in total protein concentra-
tion and no correlation of protein concentration and the
number of cytokeratin bands was detected.
In this study we were able to identify cytokeratins in
mechanically ventilated patients. Our protocol was not
designed to explore the mechanisms of cytokeratin release
or their origins, but their presence shows that there is some
relation to ventilatory aspects, as the number of cytoker-
atins detected in EBC correlates with ventilatory parameters
and indicators of pulmonary (concentration in EBC) and
systemic (concentration in serum) inflammation. The in-
flammatory indicators were not significantly correlated with
the EBC cytokeratin content (Table 3). Cytokeratin 19,
which was not detectable in EBC from any patient in this
study was reported to be increased in bronchoalveolar
lavage In chronic inflammatory airway disease.28 Other
authors have described changes of the cytokeratin expres-
sion pattern to be a cellular stress response caused e.g. by
cigarette smoke in the respiratory tract of rats.29 Gianazza
et al. described detection of cytokeratins CK-1 and CK-9 in
EBC of heavy smokers (40 pack-years). These authors were
not able to detect protein bands in one-dimensional
electrophoresis when using 1–1.3ml of EBC.2 In the current
study efforts were made to increase the amount of proteins
and therefore used 10ml of EBC that was lyophilized before
use in electrophoresis experiments. Nevertheless, we did
not observe any influence of the smoking status in this group
of mechanically ventilated patients on the number of
cytokeratins detected.
In our study, none of the cytokeratins that have been
detected by immunohistochemistry in the trachea (CK-15,
CK-7), lung (CK-14, CK-15), bronchi and alveoli (CK-7, CK-8,
CK-18, CK-19)30 were detectable in EBC. However, CK-9, one
of the cytokeratins observed here, has previously been
described by Gianazza et al.2 using gel electrophoresis.
These authors also detected cytokeratin CK-1 in EBC while
our experiments revealed cytokeratins CK-2 and CK-10 in
addition to CK-9. Different methods of identification
(tandem electrospray mass spectrometry vs. MALD-TOF mass
spectrometry in this study) were used and different patient
groups assessed.
Cytokeratins were detected more often and in greater
numbers in the ventilated patients with higher PIP and/or
higher PEEP pressures. Increased cellular damage following
increased alveolar distension by elevated pressures during
ventilation may be a reason for the increased release of
cytokeratins. Overdistension of lung tissue during mechan-
ical ventilation has indeed been widely recognized.31 The
duration of mechanical ventilation associated stress may
also be of influence as suggested by our finding of a weak
correlation of ventilatory time with cytokeratin detection
rate. Continuing stress acting on the lung in association with
mechanical ventilation might explain the unusual pattern of
cytokines detected, however it does not easily explain the
increase in detection rate observed in our study. Swensson
et al. observed specific cytokeratin expression in response
to high physical stress in ridged skin.24 Increased CK-7,
CK-8, CK-14, CK-17, and CK-19 were also observed in
lung tissue of patients with idiopathic pulmonary fibrosis
when compared with normal lung tissue.32 Smoking has
been identified as another cause for increased cytokeratinrelease in an experimental rat model29 and in a
clinical study of cytokeratins in EBC of heavy smokers.2
Finally, elevated levels of CK-19 were found in BALF of
patients with COPD. The presence of CK-19 was suggested to
be useful for assessing the extent of bronchial epithelial
damage.28
We have reasons to believe, that inflammatory processes
are not responsible for the increased cytokeratin detection
rate because there was no correlation in pro-inflammatory
cytokines in EBC or serum and the number of cytokeratin
bands. The fact, that inflammation does not alter cytoker-
atin expression is supported by observations of unaltered
CK-19 expression in BET-1A cells (human immortalized
bronchial epithelial cells) following stimulation with TNF-
alpha.28
High PIP was shown to be particularly damaging to
microvascular integrity.33 We observed here that elevated
PIP levels were associated with a higher rate of cytokeratin
detection in EBC. In addition a greater number of
cytokeratins were also detected when ALI was advanced as
indicated by a more severe lung injury score. This latter
observation fits well with the hypothesis of mechanical
overdistension causing increased cytokeratin detection
rates as open lung areas decrease in more severe lung
injury and the remaining open lung units are increasingly
overdistended. This observation has led to the comparison
of injured lungs with ‘‘baby lungs’’ demonstrating their
propensity to be overdistended with regular tidal volumes. A
comparable association of markers of lung distension with
ventilatory parameters was shown for nitrite and tidal
volume adapted to ideal body weight.34
We have used spontaneously breathing volunteers for
control subjects because a suitable ventilated control group
is almost impossible to recruit. This of course constitutes a
limitation of the study. However, even in surgical patients
with e.g. trauma or those undergoing general surgery, an
influence of EBC due to the disease process as well as to
ventilation would be expected. In addition, the absence of
cytokeratins in spontaneous breathing subjects in fact adds
to the suggestion of cytokeratins as a marker of ventilator
associated stress.
This study did not include repetitive measurements in the
same individuals to characterize a time course of cytoker-
atin occurrence in EBC or to correlate changes in the
EBC cytokeratin pattern with changes in the ventilatory
pattern. Therefore we cannot conclude that the EBC
cytokeratin pattern represents an appropriate clinical tool
to monitor mechanical ventilation-induced mechanical
stress on the lung tissue. However, EBC cytokeratin pattern
seems to be promising candidate that justifies further
clinical investigations.
In conclusion, we were able to demonstrate an increased
frequency of cytokeratin detection in EBC samples of
mechanically ventilated patients with ALI/ARDS as defined
by standard criteria. Increased cytokeratin detection rates
were correlated with higher PIP and PEEP levels, more
severely injured lungs and longer ventilation. These findings
suggest that mechanical stress caused by ventilation and
aggravated by the extent of concomitant lung damage
somehow leads to an increased number of cytokeratins
detectable in EBC. Thus, the presence of cytokeratins and
their number detected in EBC may serve as an indicator of
ARTICLE IN PRESS
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injury.
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